Author

R. Vogels

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Animal Behavior & Cognition· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:deep learning· 1 Assay:imaging· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:protein structure· 1 Research Focus:synaptic & neural circuits· 1

Frequent Co-Authors

D. Zuijdgeest· 2 shared H. Schuitemaker· 2 shared J. Custers· 2 shared J. P. Langedijk· 2 shared R. Bos· 2 shared A. Bognar· 1 shared A. H. de Wilde· 1 shared A. Koornneef· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. Zuijdgeest

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MacAction: Realistic 3D macaque body animation based on multi-camera markerless motion capture

L. M. Martini, A. Bognar, R. Vogels, M. A. Giese

The paper develops a pipeline for realistic 3D macaque body animation using multi-camera markerless motion capture, showing high accuracy and perceptual similarity to real videos.

bioRxiv · Jan 29, 2024 · PreprintAnimal Behavior & Cognition

Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern

M. Jongeneelen, K. Kaszas, D. Veldman, J. Huizingh, R. van der Vlugt, T. Schouten, D. Zuijdgeest, T. Uil, G. van Roey, N. Guimera, M. Navis, R. Bos, M. Le Gars, J. Sadoff, L. Muchene, , B. Brandenburg

This study evaluates the neutralizing activity of Ad26.COV2.S vaccine sera against SARS-CoV-2 variants, finding reduced effectiveness against Beta and Gamma but less reduction against Delta.

bioRxiv · Jul 1, 2021 · PreprintImmunology

Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

R. Bos, L. Rutten, J. E. M. van der Lubbe, M. J. G. Bakkers, G. Hardenberg, F. Wegmann, D. Zuijdgeest, A. H. de Wilde, A. Koornneef, A. Verwilligen, D. van Manen, T. Kwaks, R. Vogels, T. J. Dalebout, S. K. Myeni, , H. Schuitemaker

This paper evaluates a prefusion-stabilized SARS-CoV-2 Spike protein vaccine candidate, Ad26.COV2.S, showing potent neutralizing and Th1-polarized immune responses in mice.

bioRxiv · Jul 30, 2020Immunology